Diagnosis and Treatment of Cholangiocarcinoma

Diagnosis and Treatment of Cholangiocarcinoma Christopher D. Anderson, C. Wright Pinson, Jordan Berlin, Ravi S. Chari Oncologist 2004; 9: 43-57 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in hepatobiliary and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the current state-of-the-art treatment of cholangiocarcinoma including the current results of aggressive resection, adjuvant therapies, and neoadjuvant therapies. Outline the criteria for determining resectability. Discuss the roles of chemotherapies and radiation therapies in the palliative care of the patient with unresectable cholangiocarcinoma. Identify the roles of operative bypass and endoscopic or percutaneous stenting in the palliation of cholangiocarcinoma. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 30, 2004 Most Recent Review: Jan. 30, 2004* Most Recent Update: Jan. 30, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.